Ready to Help Whenever You Need Us
We know who to talk to, where to find answers, and what steps you need to take. Let us put our 30 years of experience to work for you.
The Food and Drug Administration (FDA) has announced new labeling for the eczema drugs Elidel Cream and Protopical Ointment that warn patients and healthcare providers of the potential risk of cancer. The FDA had previously released a public health advisory warning of the potential link between the use of these eczema drugs and cancer.
A definitive casual link between these eczema drugs and cancer has not been established. However, rare reports of skin cancer and lymphoma in patients and animal studies are a cause for concern.
The FDA has issued the following recommendations regarding the use of Elidel:
- Elidel should not be the first drug you use to treat eczema. It should be used only when all other medications have failed, or you had too many side effects from other drugs.
- Elidel is not approved for use in children under the age of 2. Elidel may negatively affect the developing immune system in infants and children.
- Use Elidel only for short periods of time. The continuous, long-term effects of the drug are still unknown.
- Use the minimum amount of Elidel necessary for treatment.
Eczema is a common skin disorder that affects about 15 percent of the childhood population.
If you or your loved one has suffered an eczema drug injury, contact us today. Submit the form to the right and we’ll let you know if you have a case and if we can represent you.